Literature DB >> 15482961

Two novel mutations in the spastin gene (SPG4) found by DHPLC mutation analysis.

Michele Falco1, Carmela Scuderi, Sebastiano Musumeci, Maurizio Sturnio, Marcella Neri, Stefania Bigoni, Luisa Caniatti, Marco Fichera.   

Abstract

The most common form of autosomal dominant hereditary spastic paraplegia is caused by mutations in the gene encoding spastin (SPG4), a member of the AAA family of ATPases. In the current study, we designed a denaturing high-performance liquid chromatography based protocol for the analysis of the SPG4 gene. Using this method, we detected two novel missense mutations, 1375A > G (R459G) and 1378C > T (R460C), one previously described five bases deletion (1215_1219del) and three polymorphic changes. This study suggests that denaturing high-performance liquid chromatography would be a fast and reliable tool in the investigation of the molecular defects in the SPG4 gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482961     DOI: 10.1016/j.nmd.2004.05.017

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

1.  Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses.

Authors:  Hiroyuki Ishiura; Yuji Takahashi; Toshihiro Hayashi; Kayoko Saito; Hirokazu Furuya; Mitsunori Watanabe; Miho Murata; Mikiya Suzuki; Akira Sugiura; Setsu Sawai; Kazumoto Shibuya; Naohisa Ueda; Yaeko Ichikawa; Ichiro Kanazawa; Jun Goto; Shoji Tsuji
Journal:  J Hum Genet       Date:  2014-01-23       Impact factor: 3.172

Review 2.  Genotype-phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients.

Authors:  Maryam Erfanian Omidvar; Shahram Torkamandi; Somaye Rezaei; Behnam Alipoor; Mir Davood Omrani; Hossein Darvish; Hamid Ghaedi
Journal:  J Neurol       Date:  2019-11-19       Impact factor: 4.849

3.  Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases.

Authors:  C Depienne; C Tallaksen; J Y Lephay; B Bricka; S Poea-Guyon; B Fontaine; P Labauge; A Brice; A Durr
Journal:  J Med Genet       Date:  2005-07-31       Impact factor: 6.318

4.  Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4.

Authors:  Francisco Grandas; Manuel Desco; Francisco J Navas-Sánchez; Alberto Fernández-Pena; Daniel Martín de Blas; Yasser Alemán-Gómez; Luís Marcos-Vidal; Juan A Guzmán-de-Villoria; Pilar Fernández-García; Julia Romero; Irene Catalina; Laura Lillo; José L Muñoz-Blanco; Andrés Ordoñez-Ugalde; Beatriz Quintáns; Julio Pardo; María-Jesús Sobrido; Susanna Carmona
Journal:  J Neurol       Date:  2021-01-28       Impact factor: 4.849

5.  Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia.

Authors:  D S McCorquodale; U Ozomaro; J Huang; G Montenegro; A Kushman; L Citrigno; J Price; F Speziani; M A Pericak-Vance; S Züchner
Journal:  Clin Genet       Date:  2011-06       Impact factor: 4.438

6.  Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia.

Authors:  Moneef Shoukier; Juergen Neesen; Simone M Sauter; Loukas Argyriou; Nadine Doerwald; D V Krishna Pantakani; Ashraf U Mannan
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

7.  SPAST mutation spectrum and familial occurrence among Czech patients with pure hereditary spastic paraplegia.

Authors:  Anna Uhrová Mészárosová; Martina Putzová; Marie Čermáková; Dagmar Vávrová; Kateřina Doležalová; Irena Smetanová; David Stejskal; Christian Beetz; Pavel Seeman
Journal:  J Hum Genet       Date:  2016-06-23       Impact factor: 3.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.